Francesco Lanza

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

Francesco Passamonti, Chiara Cattaneo, Luca Arcaini et al. · The Lancet Haematology · 2020 · 551 citations · Full text

GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia

Adriano Venditti, Alfonso Piciocchi, Anna Candoni et al. · Blood · 2019 · 208 citations · Full text

The Reliability and Specificity of c-kit for the Diagnosis of Acute Myeloid Leukemias and Undifferentiated Leukemias

Marie C. Béné, Michel Bernier, Olivier Casasnovas et al. · Blood · 1998 · 192 citations

Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients

Alexandros Spyridonidis, Myriam Labopin, Bipin N. Savani et al. · Bone Marrow Transplantation · 2020 · 191 citations · Full text

Hematological Malignancy, Transplantation, Mixed-phenotype Acute Leukemia +8

Structural and functional features of the CD34 antigen: an update.

Francesco Lanza, Lyn Healy, D. Robert Sutherland · PubMed · 2001 · 154 citations

Immunology, Glycobiology, Blood Cell +17